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Abstract
Aims/hypothesis The aim of this study was to measure the
efficacy of motivational interviewing (MI) compared with
usual care on changes in glycaemic control and competence
of diabetes self-management in patients with diabetes
mellitus.
Methods Patients were eligible if they had type 1 or 2
diabetes mellitus, were over 18 years of age and had
participated in a 4 day group education programme offered
at a diabetes clinic at a university hospital in Denmark.
Exclusion criteria included pregnancy, severe debilitating
disease and cognitive deficit. Out of 469 patients who
attended the group education programme, 349 patients were
randomised to either a usual care control group or an
intervention group, which received up to five individual
counselling sessions in 1 year based on MI, in addition to
usual care. A randomised parallel design was used and open-
label allocation was done by random permuted blocks, with
allocation concealment by sequentially numbered, sealed,
opaque envelopes. The primary outcome was glycated
haemoglobin (HbA1c). Analysis regarding measurements of
glycated haemoglobin (HbA1c) and competence of self-
management (using the Problem Areas in Diabetes Scale
[PAID] and Perceived Competence for Diabetes Scale
[PCDS]) was based on 298 participants followed for a 24
month period. Data were collected at the Department of
Endocrinology at Odense University Hospital. Our hypothe-
ses were that MI could: (1) reduce HbA1c levels; (2) increase
self-efficacy; and (3) increase diabetes self-care, compared
with usual care.
Results Out of the 176 included in the control group and
173 in the intervention group, 153 and 145 were analysed
in the groups, respectively. When using the baseline value
as covariate there were no significant differences in change
score between the two study groups with regard to mean
level of HbA1c (0.131, p=0.221), PAID scores (−1.793,
p=0.191) or PCDS scores (0.017, p=0.903) at the 24 month
follow-up, using a mixed effects regression model. The
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patients in the intervention group showed significantly
higher levels of perceived competence in dealing with
diabetes compared with the control group (mean change
score=−0.387, p=0.002) following 1 year of intervention.
Conclusion/interpretation We were unable to demonstrate
any benefit, over or above usual care, of MI in patients with
diabetes who have just completed a diabetes education
programme, and who have well-regulated diabetes.
Trial registration Clinical Trials NCT00555854.
Funding The National Board of Health, Funen County,
Danish Association of Diabetes, Odense University Hospital,
University of Southern Denmark and TRYG Fonden.
Keywords Clinical trial . Diabetes mellitus . Motivation .
Patient education . Self care
Abbreviations
MI Motivational interviewing
MITI Motivational Interviewing Treatment Integrity
OHA Oral hypoglycaemic agents
PAID Problem Areas in Diabetes
PCDS Perceived Competence for Diabetes Scale
Introduction
Self-management of diabetes requires that patients are able
to reconcile their resources and preferences with the
therapeutic regimen of diabetes, which can be a challenging
task for many patients [1, 2]. It has been widely accepted
that diabetes education is not only required in the first few
months following diagnosis but is an important component
of ongoing diabetes care because of the onerous require-
ments for self-care that demand multiple daily decisions in
order to balance diet, physical activity and medications [3].
There has been a keen interest in examining the impact of
different kinds of patient education programmes on diabetes
self-management. The findings of several meta-analyses of
randomised controlled trials provide extensive evidence for
the effectiveness of behavioural and educational interven-
tion on fasting blood glucose and glycated haemoglobin,
but the long-term effects of such interventions are uncertain
[4–8]. Knowledge about the effectiveness of behavioural
and educational intervention on other diabetes-related
outcome measures, including blood pressure, lipid profile,
body weight, self-management skills, health behaviour and
psychosocial aspects, is less clear [3, 9, 10]. Critical
assessment of the impact of behavioural and educational
programmes requires further research based on rigorous
methods in high quality studies with a large number of
participants, long-term follow-up on effectiveness and well-
defined interventions [9–11].
Motivational interviewing (MI), defined by Rollnick and
Miller, is a well-defined and scientifically tested method of
client counselling that has successfully been used to elicit
and sustain a person’s behaviour changes in a number of
healthcare areas [12]. A recent review of MI showed
improvements in health behaviour (e.g. diet and exercise) in
patients with diabetes [13]. Research has not yet been able
to establish full consensus on the effect of MI on clinical
[14–19] and psychosocial aspects [15, 18, 20–22] in
diabetes. Previous reviews emphasise the need for studies
of high methodological quality and adequate power to
explore the effect of MI on glycaemic control and well-
being in patients with diabetes [11, 13, 23].
In this study, we explored the significance of supporting
patients with diabetes to manage their diabetes over time.
The aim was to study the effect of a 1-year intervention
programme based on MI following a group education
programme on glycaemic control and competence of
management in patients diagnosed with type 1 or type 2
diabetes mellitus. Our hypotheses were that, in a sample of
people who have just completed a group education
programme, a course of motivational intervention following
group education could: (1) reduce HbA1c levels; (2)
increase self efficacy; and (3) increase diabetes self-care,
compared with usual care.
Method
Research settings
This study was conducted at a diabetes clinic, located within a
university hospital in Denmark with an intake of patients from
both urban and rural areas in the region. The hospital is a local
hospital with an intake area that reflects other hospital intake
areas in Denmark. Patients can be referred by their general
practitioner or other hospital departments to the diabetes
clinic. At the clinic, patients are offered ongoing individual
counselling by dietitians, nurses or physicians and group
education delivered by a multidisciplinary healthcare team
over 4 days. The 4 day diabetes education programme
includes approximately eight to ten patients and focuses on
a range of themes such as diabetes treatment, prevention of
diabetes-related complications, self-monitoring of blood
glucose, diet, physical activity, alcohol use and issues
regarding insurance. The teaching method is based on guided
self-determination designed to guide patients and professio-
nals in mutual problem-solving [24].
Research participants and design
Patients were eligible if they had type 1 or type 2 diabetes
mellitus, were over 18 years of age and had participated in
Diabetologia
the group education programme offered at the diabetes
clinic. Exclusion criteria included pregnancy, severe debil-
itating disease and cognitive deficit. The patients were
informed at day 1 and recruited at day 4 while participating
in the group education programme. Following informed
consent, the patients were randomised to either a control
group or an intervention group. Randomisation was done
immediately after participation in the group education
programme. No stratification was used. All outcome
measures were assessed at randomisation, 1 and 2 years
after randomisation in both groups. Randomisation was
generated by random permuted blocks, with allocation
concealment by sequentially numbered, sealed, opaque
envelopes. The person generating the allocation scheme
did not administer the allocation of the patients to the two
groups and was not part of the research team.
The sample size was determined by a power calculation.
With 352 patients, 176 in each group, the trial can detect a
0.4% difference in HbA1c. The power was set to 90%. This
calculation was based on a standard deviation of 1.15 in the
HbA1c value and a 5% two-sided significance level.
Usual care
Medical treatment was not part of the intervention. All
participants, irrespective of participation in the intervention
group or the control group, therefore underwent the same
routine check-up at their general practitioner or outpatient
clinic in charge of their diabetes care. This usually involved
four physician visits per year. Biochemical tests and
examinations were usually performed during the visits in
accordance with national diabetes guidelines. Individual
counselling and recommendations based on the results of the
examinations, biochemical tests and their self-monitoring of
blood glucose was given. Renewal of prescribed medication
and test strips for blood glucose monitoring were also
given at these check-ups. Patients could be referred for
individual counselling in change of diet, physical activity,
smoking habits and alcohol abuse if required by their
usual healthcare provider.
Research intervention
The theoretical approach of the intervention was based on
self-efficacy theory and MI spirit. Perceived self-efficacy is
defined as people’s beliefs about their capabilities of
producing designated levels of performance exercising
influence over events that affect their lives [25]. MI was
used as a method to facilitate this process. MI is a directive
counselling style for eliciting behaviour change by helping
patients to explore and resolve ambivalence [26, 27].
In addition to usual care, patients in the intervention
group received a 1 year MI programme consisting of five
individual counselling sessions lasting approximately
45 min and offered at 1, 3, 6, 9 and 12 months. Each
participant in the intervention group had a healthcare
professional assigned to them who was trained in MI. The
style of the interview was: (1) seeking to understand the
person’s frame of reference; (2) expressing acceptance and
affirmation; (3) eliciting and selectively reinforcing the
client’s own self-motivational statements of problem rec-
ognition, concern, desire and intention to change, and
ability to change; (4) exploring the client’s degree of
readiness to change; and (5) affirming the client’s freedom
of choice and self-direction. The role of exploring readiness
to change was that this was used as a component of the
therapeutic process and not an outcome. Each session
followed a semi-structured interview format of MI, espe-
cially developed for this intervention programme. Partic-
ipants brought up any problematic issues related to diabetes
self-care during sessions. The participants in the interven-
tion group could be referred by the healthcare professional
to individual counselling in changes of diet, a smoking
cessation programme, counselling in alcohol abuse and an
exercise programme, as they required.
Education of the healthcare professionals prior
to the intervention
Three diabetes specialist nurses, two dietitians, one physio-
therapist and one psychologist were educated to carry out
MI. They were all coached by a MI trainer from the
Motivational Interviewing Network of Trainers in the
Nordic countries. The course comprised a 5 day theoretical
introduction to strategies in MI. The course was followed
by three practical coaching sessions every 3 months for
18 months. The theoretical and practical part of the
education included training in the key elements of MI,
which is generally facilitating through eliciting change
talk and exploring ambivalence about behavioural
change, while trying to examine discrepancies between
the individual’s current behaviour and core values or
personal goals. The healthcare professionals were intro-
duced to the MI method including reflective listening and
acknowledgement to allow them to be able to clarify the
patient’s goals and concerns and elicit reasons for change
in the patient’s own words. The role of the healthcare
professionals was to coach and support the patient in
discovering and developing his/her own resources for
change and management at the patient’s request.
After the 5-day course, the healthcare professionals were
individually supervised by the MI trainer in ten real patient
situations for 1 year. The supervision included videotaping
and evaluation inspired by the Motivational Interviewing
Treatment Integrity (MITI) coding system (T. B. Moyers,
T. Martin, J. K. Manuel, W. R. Miller, D. Ernst, 2007;
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available to trainers and members of the Motivational
Interviewing Network of Trainers [MINT]). The MITI
coding system is divided into a global rating and behav-
ioural counts. The global rating is a five-point Likert scale,
where 1 indicates low competence in MI and 5 indicates
high competence in MI. The behaviour counts reveal MI
behaviour in proportion to all behaviour, where a high
percentage indicates a high competence in MI.
Measurements
Questionnaires Competence of diabetes self-management
was assessed by validated questionnaires translated into a
Danish version in accordance with recommendations [24].
The Problem Areas in Diabetes Scale (PAID) was used to
measure diabetes-related distress reported by the partici-
pants. This 20-item questionnaire assesses a wide range of
feelings related to living with diabetes and diabetes
treatment [28, 29]. Each item can be rated on a five point
Likert scale ranging from 0 (not a problem) to 4 (‘a serious
problem’). When transforming PAID scores into a 0–100
scale, all item scores are summed and multiplied by 1.25,
which results in an overall PAID score with higher scores
indicating greater emotional distress [30, 31]. High PAID
scores are associated with low self-reported adherence [29].
The Perceived Competence for Diabetes Scale (PCDS) was
used to measure competence at carrying out the diabetes
treatment regime. This is a five item questionnaire assess-
ing the degree to which participants feel confident about
dealing with diabetes [32, 33]. Each item can be rated on a
seven point Likert scale ranging from 1 (‘not true at all’) to
7 (‘very true’). The score on the PCDS is calculated by
averaging the responses on the five items. The minimum
average score is the one equalling the lowest possible
perceived competence in dealing with diabetes and the
maximum average score is 7, equalling the highest possible
perceived competence in dealing with diabetes.
Laboratory measurements One laboratory analysed all the
blood samples. Glycaemic control was assessed using HbA1c,
which was measured by a high-performance liquid
chromatography-based ion exchanged procedure (Tosho Alc
2.2, Tokyo, Japan). The reference range was 4.3–6.3%. Total
cholesterol, HDL cholesterol and triacylglycerol levels were
measured in serum by enzymatic methods (Boehringer
Mannheim Diagnostica, Mannheim, Germany). LDL-
cholesterol was calculated by Friedewald’s equation [34].
Clinical measurements Both height and weight were mea-
sured without shoes. Weight was measured without accesso-
ries, i.e. wallet, keys, mobile phone. Waist circumference was
measured with a measuring tape directly on the individual’s
skin. Restrictive garments and clothing were removed. The
tape was placed at the uppermost border of the iliac crest
horizontal to the floor. Measurement was made at the end of a
normal expiration. Blood pressure was measured by the
auscultatory method with use of a stethoscope and a
sphygmomanometer. An inflatable cuff was placed around
the upper left arm, at the same vertical height as the heart.
Measurement was made at rest in a sitting position.
Statistical analysis
For data analyses, SPSS (version 18, Chicago, IL, USA) for
Windows and STATA (version 11, College Station, TX,
USA) were used.
The baseline values are reported as means±SD or n (%).
On the basis of an intention to treat analysis, a mixed
effects regression model with random intercept was used to
compare primary and secondary outcomes at 12 and
24 months between the intervention and control groups,
where treatment was taken as the explanatory variable and
the baseline value as a covariate. Further, each outcome
was adjusted for the covariates, age, sex, type of diabetes,
level of education, HbA1c level at baseline, and healthcare
professionals delivering the intervention. A random intercept
was included in order to account for possible within-
individual dependence due to repeated measurements. In the
same fashion, a random intercept was included to account for
cluster effects due to the healthcare professionals. Results are
presented as means (95% CI). A p value of <0.05 was
regarded as statistically significant.
Research ethics
The study design was approved by the Regional Scientific
Ethics Committee of Southern Denmark (project-ID: VF-
20050131) and the study was reported to the Danish Data
Protection Agency. All patients were informed about the
aim of the study and were included in the study after
informed consent. The study was performed in accordance
with the Declaration of Helsinki.
Results
Baseline data
In the period between December 2005 and June 2009, 469
patients attended the diabetes education programme at the
diabetes clinic. Some 115 patients declined to participate in
the trial and five patients did not meet the inclusion criteria.
The reasons for declining were mainly lack of time or lack
of energy to complete the trial. Of the 120 non-participants,
62 were women and 56 were men. The distribution of sex
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was comparable in the non-participant group and the
eligible group of patients. The mean age in the non-
participant group was 59.1±11.8 years. This was signifi-
cantly higher (p=0.040) than the age of those who
participated in the trial, where the total mean age was
56.4±12.1 years. The duration of diabetes was 7.1±
10.0 years in the non-participant group and 4.7±6.7 years
in total among the participants. This difference was
significant (p=0.008). No difference was found between
the non-participant patients and the eligible patients with
regard to weight, blood pressure, HbA1c and lipid profile.
Of the 349 eligible patients, 173 patients were rando-
mised to the intervention group and 176 to the control
group. During the 2 year follow-up period, 51 participants
(15%) dropped out, of whom 28 had been allocated to the
intervention group and 23 to the control group (Fig. 1). The
baseline characteristics and health status of both groups
were similar (Table 1). We found no difference in the
characteristics of dropout participants compared with those
who remained in the study, except for the mean age, where
the dropouts were younger than the intervention group
(mean difference 4.50 years, p=0.035).
Intervention
In the intervention group, the average visits per patient
were 4.6 with an average time of 34 min per session during
the 1 year intervention programme. In the intervention
group, 85% completed the full intervention programme
with the five sessions. The last 15% in the intervention
group had between one and three sessions.
In the intervention group, 17% were referred to
individual counselling in change of diet. The mean
numbers of visit per patient were 2.0 (minimum one
and maximum five visits). Some 25% in the intervention
group were referred to an exercise programme. The mean
numbers of visits per patient were 5.7 (minimum one and
maximum 50 visits). Of the patients who participated in
dietary counselling and the exercise programme, 15%
received both therapies. Seven per cent in the interven-
tion group participated in individual counselling on
smoking cessation. The mean number of visits per
patient was 4.9 (minimum 2 and maximum 10 visits).
Finally, 3% of the patients in the intervention group were
referred to individual counselling in change of alcohol
use. No monitoring in the control group was done.
The global rating scores in the MITI coding of the
videotapes were between 4 and 5 points. The behaviour
counts showed 80–100% MI adherent behaviour in propor-
tion to the total behaviour, 76–83% of open questions in
proportion to all questions asked, 36–42% of complex
reflections in proportion to all reflections made and the
reflection to question ratio was between 0.8 and 1.8.
Random effects analysis
When using the baseline value as covariate there were no
significant differences in change in score between the two
469 patients attended the diabetes education 
programme in the diabetes clinic between 
December 2005 and June 2009. 
5 Did not meet the inclusion
   criteria   
464 eligible patients invited 
 
173 randomised to 
intervention group 
176 randomised to 
control group 
17 Dropouts due to 
 
7 During intervention 
3 Non-attendances 
2 Do not wish to participate 
1 Pregnancy 
2 Other critical disease 
2 Moving to another region
156 follow-up 1 year   
intervention group 
165 follow-up 1 year   
control group 
11 Dropouts due to 
 
2 Non-attendances 
7 Do not wish to participate 
1 Deceased   
1 Other critical disease 
  
145 follow-up 2 year   
intervention group 
153 follow-up 2 year   
intervention group 
11 Dropouts due to  
  
4 Non-attendances 
3 Do not wish to participate 
2 Other critical disease 
2 Moving to another region 
12 Dropouts due to 
 
5 Non-attendances 
2 Do not wish to participate 
1 Pregnancy 
4 Other critical disease 
115 Declined  
  
Fig. 1 Flow diagram of inclusion of the study population
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study groups with regard to mean level of HbA1c (0.131,
p=0.221), total cholesterol (0.154, p=0.110), LDL choles-
terol (0.001, p=0.981), PAID scores (−1.793, p=0.191) or
PCDS scores (0.017, p=0.903) at the 24 month follow-up
(see Table 2). Also, no statistically significant differences
were found in weight (Δmean change score=0.664,
p=0.291), waist circumference (Δmean change score=
1.366, p=0.297), systolic blood pressure (Δmean change
score=−0.145, p=0.927) or diastolic blood pressure
(Δmean change score=−0.006, p=0.995) between the
intervention and control group at the 24 month follow-up
(Table 2). The patients in the intervention group showed
significantly higher levels of perceived competence in dealing
with diabetes compared with the control group (Δmean
change score=−0.387, p=0.002) 12 months post intervention.
We found no statistically significant effect between the
healthcare professionals delivering the intervention.
Similar changes in medical treatment over time were
found in the intervention and control group as regards
insulin, oral hypoglycaemic agents (OHAs), antihyperten-
Variable Intervention (n=173) Control (n=176)
Sex
Male 90 (52) 86 (49)
Female 83 (48) 90 (51)
Age (years) 57.1±12.6 55.8±11.6
Diabetes duration (years) 4.7±6.9 4.7±6.5
Type of diabetes
Type 1 40 (23) 36 (21)
Type 2 133 (77) 140 (79)
Diagnosed retinopathy 25 (15) 20 (11)
Educational levela
≤Middle school 122 (70) 120 (68)
≥High school 51 (30) 56 (32)
Connection to the labour market
Transfer payment 109 (63) 106 (60)
Employed/self-employed 64 (37) 70 (40)
Civil status
Live alone 55 (32) 47 (27)
Cohabiting 118 (68) 129 (73)
Weight (kg) 89±18 90±19
Body mass index (kg/m²) 30.8±5.8 31.1±6.3
Waist circumference (cm) 102±15 102±15
HbA1c (%) 7.0±1.2 7.0±1.2
Blood pressure (mmHg)
Systolic 131.9±16.7 132.5±17.1
Diastolic 75.4±10.4 76.3±9.7
Cholesterol (mmol/l)
Total 4.4±1.1 4.5±1.0
LDL 2.3±1.0 2.3±0.9
HDL 1.4±0.4 1.4±0.5
Triacylglycerol 1.6±1.1 1.9±1.4
PAID 20.0±17.7 19.6±16.3
PCDS 6.3±1.0 6.1±1.1
Hypoglycaemic treatment
Insulin 47 (27) 52 (30)
OHA 80 (46) 74 (42)
Insulin and OHA 14 (8) 21 (12)
Antihypertensive treatment 104 (60) 109 (62)
Cholesterol-lowering treatment 107 (62) 119 (68)
Table 1 Characteristics of the
patients at baseline
Data are mean±SD or n (%)
aMiddle school is between
seventh and ninth grade. High
school is ninth to twelfth grade
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sive agents, cholesterol-lowering agents, anticoagulants and
steroids (electronic supplementary material [ESM] Table 1).
Discussion
The main findings of this 1 year study were that patients
with diabetes participating in a MI programme did not
improve glycaemic control or competence of self-
management in the intervention group compared with the
control group. We found that the intervention maintained
patients’ perceived competence in dealing with diabetes
compared with the control group just after the intervention.
However, this difference between the groups disappeared at
the 24 month follow-up.
The lack of effect on HbA1c, lipid profile and other
clinical outcomes such as weight and waist circumference
might indicate that the patients in the intervention group
did not change behaviour towards a higher degree of
diabetes self-care including healthy diet and more physical
activity. These findings are supported by the fact that we
found no evidence that MI improved competence of self-
management over time. This might indicate that it takes
more time before the effectiveness of MI on patients’
cognition could be seen in desirable behavioural changes
in diabetes self-management [35].
Previous meta-analyses have revealed that behavioural
and educational interventions in diabetes have produced
modest short-term improvements in glycaemic control.
There was a tendency to non-significant improvements in
Table 2 Changes in primary and secondary outcome measures over 12 and 24 months in intervention group and control group
Measure Unadjusted mean
scores±SD
Adjusted mean scores (95% CI) Analysis resultsb
Baseline 12 months 24 months ΔMeana
12 months
p12 months ΔMean
a
24 months
p24 months
HbA1c (%)
Intervention 7.02±1.20 6.93 (6.80–7.06) 7.16 (7.01–7.31) 0.029 0.757 0.131 0.221
Control 7.03±1.16 6.96 (6.83–7.08) 7.29 (7.15–7.44)
Total cholesterol (mmol/l)
Intervention 4.43±1.08 4.27 (4.16–4.39) 4.37 (4.24–4.51) 0.073 0.375 0.154 0.110
Control 4.54±1.01 4.41 (4.30–4.52) 4.59 (4.46–4.72)
LDL-cholesterol (mmol/l)
Intervention 2.35±0.99 2.31 (2.21–2.40) 2.43 (2.32–2.54) 0.008 0.908 0.001 0.981
Control 2.30±0.86 2.32 (2.32–2.42) 2.44 (2.33–2.55)
PAID
Intervention 20.0±17.7 18.5 (16.3–20.6) 19.5 (17.6–21.4) 1.522 0.321 −1.793 0.191
Control 19.6±16.3 20.2 (18.1–22.3) 17.9 (16.1–19.8)
PCDS
Intervention 6.27±1.05 6.25 (6.07–6.42) 6.03 (5.84–6.22) −0.387 0.002 0.017 0.903
Control 6.18±1.11 5.82 (5.65–5.98) 6.00 (5.81–6.19)
Weight (kg)
Intervention 89.7±17.7 89.3 (88.5–90.1) 90.8 (89.9–91.6) 0.588 0.210 0.664 0.291
Control 89.6±18.3 90.3 (89.5–91.0) 91.8 (90.9–92.6)
Waist circumference (cm)
Intervention 102.2±14.6 102.8 (102.0–103.6) 102.4 (100.6–104.3) 0.230 0.690 1.366 0.297
Control 102.4±15.1 102.9 (102.1–103.7) 103.7 (101.9–105.5)
Systolic BP (mmHg)
Intervention 131.9±16.7 135.0 (132.6–136.9) 133.3 (131.1–135.5) −2.33 0.102 −0.145 0.927
Control 132.5±17.1 132.6 (130.7–134.6) 133.1 (131.0–135.2)
Diastolic BP (mmHg)
Intervention 75.4±10.5 78.9 (77.6–80.2) 77.1 (75.8–78.4) −1.040 0.260 −0.006 0.995
Control 76.3±9.7 78.1 (76.9–79.4) 77.3 (76.1–78.6)
a The difference in mean change score between groups ([Int0−Int1]−[Con0−Con1])
b Comparison between the two groups for primary and secondary outcomes was performed by a mixed effects regression model with random intercept,
adjusting for baseline values and age, sex, type of diabetes, level of education and HbA1c level at baseline with a random intercept
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glycated haemoglobin in the included studies where the
mean HbA1c values were less than 8.5% at baseline [4–6,
36]. A tendency to a reduced effect on glycaemic control
was found in studies where the duration of diabetes was
above 9 months [6]. Our results correspond with these
findings. Essentially, MI might not improve glycaemic
control in patients who have a relatively lower HbA1c and
longer duration of diabetes, especially when general
practitioners or diabetologists see them regularly.
It appears from the mean PAID result at baseline that
patients entering into the study had a relatively low level of
diabetes-related distress. This is similar to what is found in
unselected outpatient groups [31]. The fact that the patients
had participated in an education programme before entering
into the study might be the reason for such a relatively low
level of diabetes-related distress at baseline, which might be
reflected in the follow-up measurement. The mean PCDS
results at baseline were close to the maximum score in both
the intervention and the control group, which might also be
explained by the fact that the patients had received
education in diabetes before entering the study. Patients in
the intervention group scored significantly better in per-
ceived competence in dealing with diabetes just after the
end of the intervention, compared with the control group.
This might indicate that the intervention helped patients feel
more competent in managing their diabetes. However, the
instrument has not been developed directly to be used in
clinical practice and the interpretation of how changes in
mean PCDS score have an influence on patients’ diabetes
self-management is not clear. Moreover, the ceiling effect
occurred as a high proportion of participants in the study
had maximum scores in PCDS at baseline.
This study provided insight into the effect of a
behavioural and educational intervention. Implementing
MI as a new method in diabetes care required a shift in
the healthcare professionals’ role as well as practical
training. Previous studies have shown that several barriers
have to be overcome before a new method can be applied
[37–39]. To accommodate these barriers, supervision and
practical coaching sessions were held after the theoretical
introduction to MI. It is a strength of this study that there
has been supervision, which included videotaping and
evaluation by the MITI coding system, both to facilitate
the use of MI and to ensure that the method was used
correctly in the intervention. The evaluation using MITI
coding demonstrated a high competency in using MI
among the healthcare providers in the study.
Limitations
The power calculation showed that 352 patients were
needed to show a 0.4% difference in HbA1c. Unfortunately,
several patients declined participation, which resulted in
lower statistical power than planned. The fact that we failed
to achieve our recruitment target might have hindered us
statistically in detecting a possible intervention effect and
thus we risked overlooking a real difference between
intervention and control group. Furthermore, we cannot
totally exclude the risk of contamination bias, which in this
case could occur if patients in the control group changed their
behaviours after interacting with patients in the intervention
group, or if the healthcare professionals assigned to deliver the
intervention also treated patients in the control group coming
to the diabetes clinic for routine care. Contamination bias
might diminish the magnitude of the difference between the
intervention and usual care. Most of the patients entering this
study, however, went to their general practitioner for routine
care, which might minimise the risk of contamination bias.
Nevertheless, use of a cluster design might have minimised
the possibility of contamination bias even more.
Significance
With this randomised controlled trial we were unable to
provide evidence that MI should be considered for adoption
in routine diabetes care. When implementing a new approach
in diabetes treatment, we have to consider who are most
likely to benefit from this kind of intervention. Considering
the group of patients who declined to participate in our trial, it
was evident that they were older and had had diabetes for a
longer time period than those who participated in the trial.
This could indicate that intensive interventions might be less
attractive and manageable for the older population with
diabetes. We also might speculate that behavioural interven-
tions including MI are only effective for problem behaviours
if these are associated with poor glycaemic control.
In our trial, no improvements were found in cardiovas-
cular risk profiles, whereas such improvements are often
found in pharmacological studies [40, 41] with consequent
improvements in mortality and morbidity. We did not
intervene in medical treatment and it is therefore reasonable
to assume that it was the intervention based on MI that
improved the patient’s perceived competence in diabetes
post intervention. This might indicate that behavioural and
educational intervention adds another dimension to diabetes
care, compared with medical treatment. Therefore, the
effectiveness of behavioural and educational intervention
given in addition to usual care might be best assessed with
psychological rather than biochemical variables in patients
with HbA1c levels less than 8%. This is substantiated by a
previous review that pointed out the difficulty in assessing
the unique contribution of diabetes patient education to
diabetes outcomes [42]. Another review recommended that
the evaluation of diabetes patient education, including
behavioural and educational intervention, is concentrated
on the goal of optimal adjustment to living with diabetes, as
Diabetologia
this kind of treatment is believed to play a discernable role
in knowledge, self-determination, self-management and
psychological adjustment [43].
MI proved to be a good power-generating tool for the
staff members, who need both knowledge and practical
communication tools to talk to patients about difficult
topics. Based on this knowledge, the professions involved
in clinical practice can be advanced by a more qualified
reinforcement of initiatives regarding behavioural changes
concerning lifestyle issues in a clinical setting. To succeed with
this, it is necessary to focus on the implementation process and
continuously follow up on this to achieve this goal.
Finally, we were unable to demonstrate any benefit of
MI over and above usual care in patients with well-
regulated diabetes and newly completing a diabetes
education programme.
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